Gary Downing
CHPA Chair

Gary Downing

Downing spent 12 years with Richardson-Vicks in various sales and marketing positions before joining Oral-B Laboratories in 1984 as vice president, sales, which included professional markets as well as the operations functions. 

In 1989, he joined Rhone-Poulenc Rorer as vice president of sales of the U.S. over-the-counter medicine business, became general manager in 1990, and assumed additional responsibilities for all of North America, including Canada, Mexico, and Puerto Rico in 1991. 

Downing became president of Medtech Laboratories, Inc. in April 1995, and was appointed chief executive officer in March 1998. He was named chief executive officer at Lansinoh Laboratories, Inc. in 2002 and assumed the position of chief executive officer with Insight Pharmaceuticals in March of 2010. He successfully negotiated the sale of Insight’s products in September 2014 and helped found and acquire products for Clarion Brands where he serves as chief executive officer. 

Education: B.S., Marketing, Southeast Missouri State University 

CHPA Leadership:
Executive Committee, 2000-2001, 2012-2014, 2016-; Elected to Board of Directors, 1991, 1995, 2003, 2010, 2015